Trial record 1 of 3 for:    atomoxetine and Mild cognitive impairment
Previous Study | Return to List | Next Study

Effects of Atomoxetine in Mild Cognitive Impairment (ATX-001)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Emory University
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Allan I Levey, MD, Emory University
ClinicalTrials.gov Identifier:
NCT01522404
First received: January 25, 2012
Last updated: May 20, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)